Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial. (Q50602241)
Jump to navigation
Jump to search
scientific article published in July 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial. |
scientific article published in July 2009 |
Statements
Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial. (English)
1 reference
Roxana Mehran
1 reference
Gregg W Stone
1 reference
Cindy L Grines
1 reference
Alexandra J Lansky
1 reference
Giulio Guagliumi
1 reference
Eugenia Nikolsky
1 reference
Thomas Stuckey
1 reference
James E Tcheng
1 reference
Mark Turco
1 reference
H Mehrdad Sadeghi
1 reference
David A Cox
1 reference
Eulogio Garcia
1 reference
John J Griffin
1 reference
Martin Fahy
1 reference
1 July 2009
1 reference
2
1 reference
7
1 reference
624-632
1 reference
Identifiers
1 reference